Omega Fund Management, LLC Essa Pharma Inc. Transaction History

Omega Fund Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$24.17 - $34.28 $209,626 - $297,310	-8,673 Reduced 2.57%	328,196 $9.38 Million
Q1 2021 May 17, 2021	SELL	$11.61 - $32.08 $4.28 Million - $11.8 Million	-368,824 Reduced 52.26%	336,869 $9.79 Million
Q4 2020 Feb 16, 2021	SELL	$5.47 - $12.1 $1.13 Million - $2.5 Million	-207,000 Reduced 22.68%	705,693 $8.42 Million
Q3 2020 Nov 16, 2020	SELL	$6.0 - $7.79 $3.51 Million - $4.56 Million	-584,755 Reduced 39.05%	912,693 $6.1 Million
Q2 2020 Aug 17, 2020	SELL	$3.71 - $6.2 $713,804 - $1.19 Million	-192,400 Reduced 11.39%	1,497,448 $9.28 Million
Q1 2020 May 14, 2020	SELL	$3.23 - $5.87 $64,600 - $117,400	-20,000 Reduced 1.17%	1,689,848 $6.76 Million
Q3 2019 Nov 13, 2019	BUY	$1.46 - $3.37 $912,500 - $2.11 Million	625,000 Added 57.61%	1,709,848 $5.76 Million
Q3 2018 Nov 07, 2018	BUY	$2.67 - $4.23 $2.9 Million - $4.59 Million	1,084,848 New	1,084,848 $3.26 Million

31M

24.1K

15.1K

Ticker EPIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,073,100
Market Cap $75.8M
Description
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...

Get notified when there are updates to the investment portfolio of Omega Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Omega Fund Management, LLC with notifications on news.